The 15 of the 157 is because its a pentadeca peptide
Who Should Avoid It No safety studies on four-peptide combination Long-term effects completely unknown FDA has not approved any component for therapeutic use Stop Right Away If You Notice Severe injection site reactions or infection Allergic reactions (rash, difficulty breathing) Unusual fatigue or weakness Signs of copper toxicity (nausea, jaundice) Worsening of underlying conditions Milder Signs to Watch For How Long Should a Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) Cycle Last
There are in general three reasons for this ignorance of the prevalence of common diseases , the lack of specificity of particular drugs for particular diseases, and the lack of standardisation of therapy
Evolocumab and alirocumab have demonstrated cardiovascular outcome benefits in large randomized trials
doi:10.1093/ajcn/80.6.1551 Funk RS, Jones J, Polireddy K, et al
Alcohol disrupts protein synthesis while tobacco compromises circulation and oxygen delivery to healing tissues